GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Net-Net Working Capital

Sona Nanotech (XCNQ:SONA) Net-Net Working Capital : C$0.00 (As of Jan. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Sona Nanotech's Net-Net Working Capital for the quarter that ended in Jan. 2025 was C$0.00.

The industry rank for Sona Nanotech's Net-Net Working Capital or its related term are showing as below:

XCNQ:SONA's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 4.955
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Sona Nanotech Net-Net Working Capital Historical Data

The historical data trend for Sona Nanotech's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Net-Net Working Capital Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.02 -0.01 -0.02 0.01

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 0.01 -

Competitive Comparison of Sona Nanotech's Net-Net Working Capital

For the Diagnostics & Research subindustry, Sona Nanotech's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Price-to-Net-Net-Working-Capital Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Price-to-Net-Net-Working-Capital falls into.


;
;

Sona Nanotech Net-Net Working Capital Calculation

Sona Nanotech's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Oct. 2024 is calculated as

Net-Net Working Capital(A: Oct. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.859+0.75 * 0.097+0.5 * 0-1.237
-0-0)/111.720
=0.01

Sona Nanotech's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jan. 2025 is calculated as

Net-Net Working Capital(Q: Jan. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.448+0.75 * 0.099+0.5 * 0-1.476
-0-0)/111.720
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Sona Nanotech  (XCNQ:SONA) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Sona Nanotech Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines